from
TF Market Research35 page report
published Nov 07, 2007
Price
$1,400.00 available for immediate download
This report is also available for purchase on a
per-page basis.
Report Overview
Purchase by Section
Search Inside
...Drug Houses of Australia (Asia) Pte. Ltd. (DHA), a wholly-owned subsidiary of Haw Par Healthcare, is a leading name among manufacturers of pharmaceutical pr oducts. The company was established in ####. Its philosophy is to provide reliable and quality pharmaceutic al products through stringent quality control. DHA's laboratory is equipped with state-of-the-art testing equipment such as gas chromatographs, liquid chromatographs, atomic absorption spectrophotomet er, ultra-violet-spectroph otometers, FT-infra-red spectrophotometer, tablet-t esting machine, autotitrators and other analytical instruments. DHA manufactures Tablets (plain, coated), Capsules, Cr eams/ Ointments, Granules/ Powders, Liquid preparations- syrups, suspensions, emulsions and so lutions. The company also produces contract manufacture OTC products and Chinese Proprietary Medici nes (CPM). DHA markets and distributes its products to Private clinics & Group practices, Hospital s (private and restructured)...
Source: LIFE SCIENCE ANALYTICS
Author: HARINATHA, G.
Company: DRUG HOUSES OF AUSTRALIA ASIA PTE LTD
Geographic Regions: ASIAN CONTINENT, SOUTHEAST ASIA, SINGAPORE
|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| Company Information | 1 | 1 |
| Drug Houses of Australia (Asia) Pte. Ltd. [NonUS -- Symbol : Private] | 1 | 1 |
| Formation Date: 1969 | 1 | 1 |
| Business Summary | 1 | 1 |
| Product Glance | 3 | 1 |
| Diseasehub Classification | 3 | 1 |
| Product Summary | 4 | 3 |
| Product Details | 7 | 1 |
| 1. Cementin (cimetidine) | 7 | 1 |
| Description | 7 | 5 |
| Therapeutic | 7 | 1 |
| Drug Class | 7 | 1 |
| Trial Details | 8 | 1 |
| Last Updated | 8 | 1 |
| Current Trial | 8 | 18 |
| Therapeutic | 9 | 1 |
| Drug Class | 9 | 1 |
| 6. Zendhin (ranitidine hydrochloride) | 9 | 1 |
| Last Updated | 10 | 1 |
| 9. Zenmolin (salbutamol sulphate) | 10 | 1 |
| 10. Glibenclamide | 10 | 1 |
| Trial Details | 11 | 1 |
| Therapeutic | 11 | 9 |
| Drug Class | 11 | 1 |
| Last Updated | 12 | 2 |
| 19. Doridone (domperidone) | 12 | 1 |
| 20. Metoclopramide | 13 | 1 |
| Description | 13 | 1 |
| Drug Class | 13 | 3 |
| 26. DHA- Simvastatin | 14 | 1 |
| Last Updated | 15 | 1 |
| Trial Details | 15 | 3 |
| Description | 16 | 3 |
| Last Updated | 17 | 1 |
| 34. Propylthiouracil | 17 | 1 |
| 38. DHA- Clarithromycin | 18 | 1 |
| Drug Class | 18 | 5 |
| 40. Dhatracin (tetracycline hydrochloride) | 19 | 1 |
| Trial Details | 19 | 4 |
| Last Updated | 19 | 2 |
| 44. Trizine (timethoprim, sulphadiazine) | 20 | 1 |
| Description | 20 | 2 |
| Last Updated | 22 | 14 |
| 51. Dhacold (paracetamol, pseudoephedrine, chlorpheniramine maleate, caffeine) | 22 | 1 |
| Therapeutic | 22 | 1 |
| 54. Dhactulose (lactulose) | 23 | 1 |
| 57. Pharynx lozenges (benzocaine, cetylpyridinium chloride) | 23 | 1 |
| Trial Details | 24 | 1 |
| 58. Glycerin thymol gargle (glycerin, methyl salicylate, thymol menthol, borax, sodium salicylate, sodium benzoate) | 24 | 1 |
| Therapeutic | 24 | 1 |
| 63. Dhacodine (pholcodine) | 25 | 1 |
| Description | 25 | 4 |
| Drug Class | 25 | 7 |
| 65. Dhasedyl DM (dextromethorphan Hbr, promethazine HCl, ephedrine HCl ) | 26 | 1 |
| Trial Details | 26 | 1 |
| Current Trial | 27 | 1 |
| 71. Promethazine | 27 | 1 |
| 72. Vasican (bromhexine HCl) | 28 | 1 |
| 73. Betasone (betamethasone) | 28 | 1 |
| Current Trial | 29 | 1 |
| Trial Details | 29 | 2 |
| Therapeutic | 29 | 6 |
| 80. Difenac (diclofenac sodium ) | 30 | 1 |
| Description | 30 | 2 |
| Current Trial | 31 | 4 |
| 83. Picapan (paracetamol, caffeine) | 31 | 1 |
| Trial Details | 32 | 3 |
| 87. DHA-Glucosamine sulphate | 32 | 1 |
| 90. Natural vitamin E 400IU licap | 33 | 1 |
| Description | 33 | 2 |
TF Market ResearchTF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.
